JPH0233008B2 - - Google Patents

Info

Publication number
JPH0233008B2
JPH0233008B2 JP56038327A JP3832781A JPH0233008B2 JP H0233008 B2 JPH0233008 B2 JP H0233008B2 JP 56038327 A JP56038327 A JP 56038327A JP 3832781 A JP3832781 A JP 3832781A JP H0233008 B2 JPH0233008 B2 JP H0233008B2
Authority
JP
Japan
Prior art keywords
hydroxymethyl
wound healing
group
compound
trimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56038327A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57154123A (en
Inventor
Shinsaku Kobayashi
Akira Ogiso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP56038327A priority Critical patent/JPS57154123A/ja
Priority to US06/353,887 priority patent/US4434179A/en
Priority to GB8206959A priority patent/GB2095996B/en
Priority to PH26990A priority patent/PH17350A/en
Priority to CH594/85A priority patent/CH652303A5/de
Priority to CH1640/82A priority patent/CH647948A5/de
Priority to FR8204494A priority patent/FR2502006A1/fr
Priority to DE19823209722 priority patent/DE3209722A1/de
Priority to IT67345/82A priority patent/IT1191173B/it
Publication of JPS57154123A publication Critical patent/JPS57154123A/ja
Publication of JPH0233008B2 publication Critical patent/JPH0233008B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP56038327A 1981-03-17 1981-03-17 Remedial promotor for wound Granted JPS57154123A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP56038327A JPS57154123A (en) 1981-03-17 1981-03-17 Remedial promotor for wound
US06/353,887 US4434179A (en) 1981-03-17 1982-03-02 Wound-healing promoters
GB8206959A GB2095996B (en) 1981-03-17 1982-03-10 Wound-healing promoters containing polyprenyl derivatives
PH26990A PH17350A (en) 1981-03-17 1982-03-15 Wound healing promoters
CH594/85A CH652303A5 (de) 1981-03-17 1982-03-16 Verwendung von polyprenylderivaten fuer die herstellung eines mittels fuer die aeusserliche behandlung von wunden oder von suppositorien fuer die behandlung von wunden bei menschen und tieren.
CH1640/82A CH647948A5 (de) 1981-03-17 1982-03-16 Mittel fuer die aeusserliche behandlung von wunden oder suppositorien fuer die behandlung von wunden bei menschen und tieren.
FR8204494A FR2502006A1 (fr) 1981-03-17 1982-03-17 Composes polyprenyliques favorisant la guerison des plaies et compositions les contenant
DE19823209722 DE3209722A1 (de) 1981-03-17 1982-03-17 Wundenheilende promotoren
IT67345/82A IT1191173B (it) 1981-03-17 1982-03-17 Composto e composizione farmaceutica per accelerare la cicatrizzazione di ferite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56038327A JPS57154123A (en) 1981-03-17 1981-03-17 Remedial promotor for wound

Publications (2)

Publication Number Publication Date
JPS57154123A JPS57154123A (en) 1982-09-22
JPH0233008B2 true JPH0233008B2 (enExample) 1990-07-25

Family

ID=12522180

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56038327A Granted JPS57154123A (en) 1981-03-17 1981-03-17 Remedial promotor for wound

Country Status (8)

Country Link
US (1) US4434179A (enExample)
JP (1) JPS57154123A (enExample)
CH (2) CH652303A5 (enExample)
DE (1) DE3209722A1 (enExample)
FR (1) FR2502006A1 (enExample)
GB (1) GB2095996B (enExample)
IT (1) IT1191173B (enExample)
PH (1) PH17350A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658958A (en) * 1982-05-28 1997-08-19 Eisai Co., Ltd. β, γ-dihydropolyprenyl alcohol derivatives effective at mitigating stress in animals
US5280048A (en) * 1982-05-28 1994-01-18 Eisai Co., Ltd. β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
US4784849A (en) * 1983-08-15 1988-11-15 Tutsky Ronald J Skin care and shaving compositions
US4525344A (en) * 1983-08-15 1985-06-25 Tutsky Ronald J Skin care and shaving composition
US5272139A (en) * 1986-08-27 1993-12-21 Cary George R Jr Amelioration or elimination of postoperative pain
US5475029A (en) * 1993-07-08 1995-12-12 The Board Of Trustees Of The Leland Stanford Junior University Farnesyl compounds as cholesterol lowering agents
RU2141318C1 (ru) * 1993-12-01 1999-11-20 Санкио Компани Лимитед Ингибитор образования воспалительного цитокина, средство для профилактики и лечения воспалительных заболеваний пищеварительного тракта и синдрома бехчета, способ профилактики и лечения воспалительных заболеваний и язвенного колита
US7288622B1 (en) * 2006-09-19 2007-10-30 Issar Pharmaceuticals Pvt Ltd Composition for treatment of burns and wounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1057517A (en) * 1965-12-11 1967-02-01 Chia Ah Jian A pharmaceutical composition for the treatment of tuberculosis
US4059641A (en) 1975-11-18 1977-11-22 Sankyo Company Limited Polyprenyl derivatives
JPS52131507A (en) * 1976-04-24 1977-11-04 Sankyo Co Ltd Polyprenyl derivatives

Also Published As

Publication number Publication date
IT8267345A1 (it) 1983-09-17
IT1191173B (it) 1988-02-24
GB2095996B (en) 1984-08-30
CH647948A5 (de) 1985-02-28
CH652303A5 (de) 1985-11-15
FR2502006B1 (enExample) 1984-11-16
JPS57154123A (en) 1982-09-22
FR2502006A1 (fr) 1982-09-24
GB2095996A (en) 1982-10-13
DE3209722A1 (de) 1982-10-21
DE3209722C2 (enExample) 1989-10-26
US4434179A (en) 1984-02-28
IT8267345A0 (it) 1982-03-17
PH17350A (en) 1984-08-01

Similar Documents

Publication Publication Date Title
US4078060A (en) Method of inducing an estrogenic response
EP0085579B1 (en) Topical pharmaceutical compositions
US4871752A (en) Use of aryloxycarboxylic acid derivatives against dermatological diseases
JPH0233008B2 (enExample)
KR960700728A (ko) 진행성 조직 괴사, 재관류 손상, 세균 전이 및 성인 호흡 장애 증후군의 예방 방법(Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome)
CH637949A5 (en) Process for the preparation of novel sodium salts of prostaglandin derivatives
IL90410A (en) Pharmaceutical product comprising an oestrogen and a pure antioestrogen and pharmaceutical compositions comprising said product
JPS6289694A (ja) ２１−置換チオステロイド化合物
DE3108323A1 (de) Oxytocin-derivat
US5625083A (en) Dinitroglycerol esters of unsaturated fatty acids and prostaglandins
JPH05213744A (ja) 炎症性疾患の処置のための薬剤調製物
JPH07165587A (ja) 抗肥満剤
CA2139209A1 (en) Therapeutic agent for hemorrhoidal diseases
US4190669A (en) Method for treating psoriasis
RU2125446C1 (ru) Антиглюкокортикоидное лекарственное средство
DE69637313T2 (de) Verwendung von stickstoffoxyddonoren oder -antagonisten zur regulierung der dehnung der zervix
US3689667A (en) C22 acid and its salts to promote wound healing
US4876281A (en) Antifungal agents
JP3038519B2 (ja) 創傷治癒促進剤
RU2225208C1 (ru) Фармацевтическая композиция, обладающая противовоспалительным и антиаллергическим действием
KR19980701958A (ko) 신규 제약 제형
US4252800A (en) 7α-methylnorethindrone enanthate and its use in long term suppression of fertility in female mammals
JP2749778B2 (ja) トリアムシノロン誘導体
SE432101B (sv) Prostacyklinderivat for anvendning att reglera reproduktionscykeln hos menstruerande hondeggdjur
CA1316460C (en) Use of glycerol ether for epidermal growth